| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3226588 | The American Journal of Emergency Medicine | 2007 | 6 Pages |
Abstract
Heparin-PF4 antibody prevalence is 7.4% in ED patients with chest pain or thrombosis, with â¼1 in 3 seropositive patients having platelet-activating antibodies. Alternative, nonheparin anticoagulation would be prudent in these at-risk patients.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
John L. PhD, Alane MS, RN, Mary RN, Jamie M. BS, Marcie J. PhD, Robert L. MD,